References
- Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi:https://doi.org/10.1164/rccm.200801-060ST.
- Global Initiative for Asthma, 2020. Global strategy for asthma management and prevention. Available from: https://ginasthma.org. Accessed 1st June 2020.
- Desai D, Siddiqui S, Brightling C. Can inhaled corticosteroids prevent asthma exacerbations? Curr Opin Pulm Med. 2011;17(1):16–22. doi:https://doi.org/10.1097/MCP.0b013e3283410acd.
- McKeever T, Mortimer K, Wilson A, Walker S, Brightling C, Skeggs A, Pavord I, Price D, Duley L, Thomas M, et al. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. N Engl J Med. 2018;378(10):902–910. doi:https://doi.org/10.1056/NEJMoa1714257.
- Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Löfdahl CG, Pauwels RA, Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160(2):594–599. doi:https://doi.org/10.1164/ajrccm.160.2.9811100.
- Kupczyk M, Haque S, Sterk PJ, Niżankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Dahlén B, Gaga M, Gjomarkaj M, on behalf of the BIOAIR investigators, et al. BIOAIR investigators. Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax. 2013;68(7):611–618. doi:https://doi.org/10.1136/thoraxjnl-2012-201815.
- Honkoop PJ, Taylor DR, Smith AD, Snoeck-Stroband JB, Sont JK. Early detection of asthma exacerbations by using action points in self-management plans. Eur Respir J. 2013;41(1):53–59. doi:https://doi.org/10.1183/09031936.00205911.
- Gonem S, Janssens W, Das N, Topalovic M. Applications of artificial intelligence and machine learning in respiratory medicine. Thorax. 2020;75(8):695–701. doi:https://doi.org/10.1136/thoraxjnl-2020-214556.
- Finkelstein J, Jeong IC. Machine learning approaches to personalize early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;1387(1):153–165. doi:https://doi.org/10.1111/nyas.13218.
- Atienza T, Aquino T, Fernández M, Boonsawat W, Kawai M, Kudo T, Ekelund J, Ivanov S, Carlsson LG. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Respirology. 2013;18(2):354–363. doi:https://doi.org/10.1111/resp.12009.
- http://scikit-learn.org/stable/modules/generated/sklearn.preprocessing.scale.html.
- https://docs.scipy.org/doc/scipy-0.14.0/reference/generated/scipy.signal.medfilt.html.
- https://docs.scipy.org/doc/scipy/reference/generated/scipy.signal.savgol_filter.html.
- https://docs.scipy.org/doc/scipy/reference/generated/scipy.signal.wiener.html#scipy.signal.wiener.
- http://scikit-learn.org/stable/modules/generated/sklearn.decomposition.PCA.html.
- He H, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21(9):1263–1284. doi:https://doi.org/10.1109/TKDE.2008.239.
- Wang S, Minku LL, Yao X. Resampling-based ensemble methods for online class imbalance learning. IEEE Trans Knowl Data Eng. 2015;27(5):1356–1368. doi:https://doi.org/10.1109/TKDE.2014.2345380.
- Bishop C. Pattern recognition and machine learning. Springer: New York, 2006.
- Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: The FENOtype trial. Chest. 2012;142(6):1553–1561. doi:https://doi.org/10.1378/chest.12-1310.
- Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63(6):655–670. doi:https://doi.org/10.4187/respcare.06314.
- Kagen S, Garland A. Asthma and allergy mobile apps in 2018. Curr Allergy Asthma Rep. 2019;19(1):6. doi:https://doi.org/10.1007/s11882-019-0840-z.
- Juniper EF, O'Byrne PM, Ferrie PJ, King DR, Roberts JN. Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med. 2000;162(4 Pt 1):1330–1334. doi:https://doi.org/10.1164/ajrccm.162.4.9912138.
- Gater A, Nelsen L, Fleming S, Lundy JJ, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, et al. Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the asthma daily symptom diary. Value Health. 2016;19(4):440–450. doi:https://doi.org/10.1016/j.jval.2016.01.007.
- Patel M, Pilcher J, Munro C, Hosking A, Pritchard A, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group. Short-acting β-agonist use as a marker of current asthma control. J Allergy Clin Immunol Pract. 2013;1(4):370–377. doi:https://doi.org/10.1016/j.jaip.2013.04.008.
- Patel M, Pilcher J, Reddel HK, Pritchard A, Corin A, Helm C, Tofield C, Shaw D, Black P, Weatherall M, SMART Study Group, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy. 2013;43(10):1144–1151. doi:https://doi.org/10.1111/cea.12166.
- Pilcher J, Patel M, Pritchard A, Thayabaran D, Ebmeier S, Shaw D, Black P, Braithwaite I, Weatherall M, Beasley R. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial. NPJ Prim Care Respir Med. 2017;27(1):33. doi:https://doi.org/10.1038/s41533-017-0032-z.
- Patel M, Pilcher J, Hancox RJ, Sheahan D, Pritchard A, Braithwaite I, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group. The Use of β2-agonist Therapy Before Hospital Attendance for Severe Asthma Exacerbations: A Post-Hoc Analysis. NPJ Prim Care Respir Med. 2015;25:14099.
- Menzies-Gow A, Mansur AH, Brightling CE. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. doi:https://doi.org/10.1183/13993003.01633-2019.
- Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax. 2018;73(12):1110–1119. doi:https://doi.org/10.1136/thoraxjnl-2018-211540.
- Pijnenburg MW, Floor SE, Hop WC, De Jongste JC. Daily ambulatory exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol. 2006;17(3):189–193. doi:https://doi.org/10.1111/j.1399-3038.2006.00394.x.
- Hashimoto S, Brinke AT, Roldaan AC, van Veen IH, Moller GM, Sont JK, Weersink EJM, van der Zee JS, Braunstahl G-J, Zwinderman AH, et al. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Thorax. 2011;66(6):514–520. doi:https://doi.org/10.1136/thx.2010.153411.
- van der Valk RJP, Baraldi E, Stern G, Frey U, de Jongste JC. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy. 2012;67(2):265–271. doi:https://doi.org/10.1111/j.1398-9995.2011.02734.x.
- Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control. Eur Respir J. 2014;43(2):474–484. doi:https://doi.org/10.1183/09031936.00048513.
- Nanda CR, Singapuri A, Soares M, Monteiro W, Siddiqui S, Gonem S. Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma. Eur Respir J. 2016;48(1):242–244. doi:https://doi.org/10.1183/13993003.02060-2015.